Preclinical activity of SAR408701, a novel anti-CEACAM5-maytansinoid antibody-drug conjugate for the treatment of CEACAM5-positive epithelial tumors
| Image |  |
|---|---|
| Description | scientific article published on 12 October 2020 |
| Author/s |
author: Claire Brillac Pierre-François Berne Anne-Marie Lefebvre Prades Catherine |
| Publication date | October 12, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |